2017

Adan A, Alizadeh G, Kiraz Y, Nalbant A, Baran Y. Flow cytometry: Basic Principles and Applications. 2017, Critical Reviews in Biotechnology.

Amuk NG, Kurt G, Baran Y, Seyrantepe V, Kartal-Yandim M, Adan A, Sönmez MF. Effects of Cell-Mediated Osteoprotegerin Gene Transfer and Mesenchymal Stem Cell Applications on Orthodontically Induced Root Resorption of Rat Teeth, In Press, 2017, European Journal of Orthodontics.

Işık S, Uzuner N, Karaman M, Karaman Ö, Kıray M, Kozanoğlu İ, Bağrıyanık HA, Arıkan-Ayyıldız Z, Kartal Yandım M, Baran Y. Potent effects of mesenchymal stem cells on murine model of bronchiolitis obliterans. Iranian Journal of Allergy, Asthma and Immunology, 2017; 16(3), 205-218.

Apohan E, Yilmaz U, Yilmaz O, Serindag A, Kucukbay H, Yesilada O, Baran Y. Synthesis, Cytotoxic and Antimicrobial Activities of Novel Cobalt and Zinc Complexes of Benzimidazole Derivatives. Journal of Organometallic Chemistry, 2017; 828, 52-58.

Işık S, Karaman M, Adan A, Kıray M, Bağrıyanık HA, Sözmen ŞÇ, Kozanoğlu İ, Karaman Ö, Baran Y, Uzuner N. Intraperitoneal Mesenchymal Stem Cell Administration Ameliorates Allergic Rhinitis in the Murine Model. European Archives of Oto-Rhino-Laryngology and Head & Neck, 2017; 274, 197-207.

2016

Adan A, Kiraz Y, Baran Y. Cell Proliferation And Cytotoxicity Assays. Current Pharmaceutical Biotechnology, 2016; 17(14): 1213-1221

Kiraz Y, Neergheen-Bhujun VS, Rummun N, Baran Y. Apoptotic Effects Of Non-Edible Parts Of Punica Granatum On Human Multiple Myeloma Cells. Basım Aşamasında, 2016, Tumor Biology.

Yandim MK, Ceylan C, Elmas E, Baran Y. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib. Basım Aşamasında, 2016, Tumor Biology.

Adan A, Baran Y. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling. Basım Aşamasında, 2016, Tumor Biology.

 Nalbant A, Kiraz Y, Baran Y. T cells in Tumor Microenvironment. Basım Aşamasında, 2016, Tumor Biology.

Adan A, Alizada G, Kiraz Y, Nalbant A, Baran Y. Flow cytometry: Basic principles and applications. Basım Aşamasında, 2016, Critical Reviews in Biotechnology.

Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Basım Aşamasında, 2016, Tumor Biology.

Emmrich S., Engeland F., El-Khatib M., Henke K, Obulkasim A, Schöning J, Katsman-Kuipers JE, Michel Zwaan C, Pich A, Stary J, Baruchel A, de Haas V, Reinhardt D, Fornerod M, van den Heuvel-Eibrink MM, Klusmann JH. miR-139-5p controls translation in myeloid leukemia through EIF4G2, Oncogene, 2016, 35(14), 1822-31.

İ.A. İşoğlu, Y. Özsoy, S. Dinçer İşoğlu, Advances in micelle-based drug delivery: Cross-linked systems, Current Topics in Medicinal Chemistry, 2016, Doi: 10.2174/1568026616666161222110600.

K. Salimi, M. Topuzoğulları, S. Dinçer, H.M. Aydın, E. Pişkin, “Microwave-asisted green approach for graft copolymerization of L-lactic acid onto starch”, Journal of Applied Polymer Science, 2016, 133, 42937.

M. Topuzoğulları, Y. Basaran Elalmıs, S. Dinçer İşoğlu, Thermo-Responsive Complexes of c-Myc Antisense Oligonucleotide with Block Copolymer of Poly(OEGMA) and Quaternized Poly(4-Vinylpyridine). Macromolecular Bioscience, 2016, Doi: 10.1002/mabi.201600263.

2015

M. Kartal Yandım, A. Adan , Y. Baran. Molecular mechanisms of drug resistance and its reversal in cancer, Critical Reviews in Biotechnology. 2015, 24,1-11 (Epub ahead of print).

A. Adan, Y. Baran. A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells, Turkish Journal of Hematology, 2015, 32(2), 118-26.

M. Kartal Yandım, A. Adan, Y. Kiraz, Y. Baran. Rejenerative Medicine. Turkiye Klinikleri J Med Oncol-Special Topics, 2015, 8(2).

A. Adan, Y. Baran. The Pleiotropic Effects of Fisetin and Hesperetin on Human Acute Promyelocytic Leukemia Cells Are Mediated through Apoptosis, Cell Cycle Arrest and Alterations in Signaling Networks, Tumor Biology, 2015, 36(11),8973-84.

B. Tezcanlı Kaymaz, N. Selvi Günel, M. Ceyhan, V. Bozok Çetintaş, B. Özel, M. Kartal Yandım, S. Kıpçak, Ç. Aktan, A. Adan, Y. Baran, B. Kosova Can. Revealing Genome Wide mRNA and microRNA Expression Patterns in Leukemic Cells Highlighted "hsa-miR-2278" as a Tumor Suppressor for Regain of Chemotherapeutic İmatinib Response due to Targeting STAT5A. Tumor Biology, 2015, 36(10),7915-27.

A. Adan, Y. Baran. Fisetin and Hesperetin Induced Apoptosis and Arrested Cell Cycle in Chronic Myeloid Leukemia Cells Accompanied by Modulation of Cellular Signaling, Tumor Biology (Epub ahead of print).

A. Katgı, O.G. Sevindik, A. Adan, G.H. Ozsan, F. Yüksel, S.M. Solmaz, I. Alacıoğlu, M.A. Ozcan, F. Demirkan, Y. Baran, O. Pişkin. Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion. Clin Appl Thromb Hemost, 2015, 21(7), 678-83

Kartal Yandım M, Adan Gokbulut A, Baran Y. Molecular Mechanisms of Drug Resistance and its Reversal in Cancer. Critical Reviews in Biotechnology, 2015; 24: 1-11.

Kaymaz BT, Günel NS, Ceyhan M, Çetintaş VB, Özel B, Yandım MK, Kıpçak S, Aktan Ç, Gökbulut AA, Baran Y, Can BK. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted Bhsa-miR-2278 as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A. Tumor Biology; 2015; 36(10): 7915-7927.

Adan A, Baran Y. The Pleiotropic Effects of Fisetin and Hesperetin on Human Acute Promyelocytic Leukemia Cells Are Mediated through Apoptosis, Cell Cycle Arrest and Alterations in Signaling Networks. Tumor Biology, 2015; 36(11): 8973-8984.

Mutlu P, Kiraz Y, Gündüz U, BaranY. An Update On Molecular Biology And Drug Resıstance Mechanısms Of Multıple Myeloma. Critical Reviews in Oncology/Hematology, 2015; 96(3): 413-424.

Cincin ZB, Unlu M, Kiran B, Bireller ES, Kiraz Y, Baran Y, Cakmakoglu B*. Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cellular Oncology, 2015; 38(3): 195-204.

Cincin ZB, Unlu M, Kıran B, Bireller ES, Baran Y, Cakmakoglu B*. Apoptotic Effects of Quercitrin in DLD-1 Colon Cancer Cell Lines. Pathology and Oncology Research, 2015: 21; 333–338.

Tufekçi O, Yandim MK, Oren H, Irken G, Baran Y. Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia. Leukemia Research, 2015: 39(3); 342-347.

Baran Y. Kanserde İlaç Dirençliliği. Günce, Türkiye Bilimler Akademisi Dergisi, 2015; 48: 67-70.

Gokbulut AA, Baran Y. A Novel Natural Product, KL-21, Inhibits Proliferation and Induces Apoptosis in Chronic Lymphocytic Leukemia Cells. Turkish Journal of Hematology, 2015; 32(2): 118-26.

Katgı A*, Sevindik OG, Gokbulut AA, Ozsan HG, Yuksel F, Solmaz SM, Alacacıoglu I, Ozcan MA, Demirkan F, Baran Y, Piskin O.  Nilotinib Does Not Alter the Secretory Funcions of Carotid Artery Endothelıal Cells in a Prothrombotic or Antithrombotic Fashion. Clinical and Applied Thrombosis/Hemostasis, 2015; 21(7): 678-83.

E. Kahraman, A. Karagöz, S. Dinçer İşoğlu, Y. Özsoy, “Polyethylenimine modified and non-modified polymeric micelles used for nasal administration of carvedilol (or medication)", Journal of Biomedical Nanotechnology, 2015, 11, 890-899.

S. Emmrich, F. Engeland, M. El-Khatib, K. Henke, J. E. Katsman-Kuipers, C. M. Zwaan, A. Pich, D. Reinhardt , M. W. J. Fornerod, M. M. van den Heuvel-Eibrink, J. H. Klusmann, miR-139-5p controls translation in myeloid leukemia through EIF4G2, Oncogene, 2015. (DOI: 10.1038/onc.2015.247)

J. J. Madsen, Y. Z. Ohkubo, G. H. Peters, J. H. Faber, E. tajkhorhsid, O. H. Olsen, Membrane interaction of the factor VIIIa discoidin domains in atomistic detail,Biochemistry, 2015, 54, 6123 (DOI: 10.1021/acs.biochem.5b00417)

2014

LY. Aydemir, A. Adan, Y. Baran, A. Yemenicioglu. Bioactive, functional and edible film making properties of different protein isolates from Turkish hazelnut (Corylus avellana L.) meal obtained from oil extraction, Food Hydrocolloids, 2014; 36,130-142. 

S. Solmaz, A. Adan, B. Cincin, H. Ozdogu, C. Boga, B. Cakmakoglu,  I. Kozanoglu,  Y. Baran. Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells. Nutrition and Cancer, 2014, 66(4),599-612.

Ömür Ö*, Baran Y, Oral A, Ceylan Y. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography For Extranodal Staging Of Non-Hodgkin Lymphoma And Hodgkin Disease. Diagnostic and Interventional Radiology 2014;0(2):185-192.

Avci CB, Baran Y. Micro RNAs in Personilized medicine. Methods in Molecular Biology; miRNomics: MicroRNA Biology and Computational Analysis, Humana Press, 2014, 1107:311-25

Aydemir LY, Adan Gokbulut A, Baran Y, Yemenicioglu A*. Bioactive, functional and edible film making properties of different protein isolates from Turkish hazelnut (Corylus avellana L.) meal obtained from oil extraction. Food Hydrocolloids, 2014; 36:130-142.

Solmaz S, Gokbulut AA, Cincin B, Ozdogu H, Boga C, Cakmakoglu B, Kozanoglu I, Baran Y. Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells. Nutrition and Cancer; An International Journal, 2014; 66(4): 599-612.

Celikkanat D, Baran Y. Comparative development of knowledge-based bioeconomy in the European Union and Turkey. Critical Reviews in Biotechnology, 2014, 34(3): 269-280.

Omur O, Baran Y.  An Update on Molecular Biology of Thyroid Cancers. Critical Reviews in Oncology/Hematology, 2014; 90(3): 233-252.

Cincin ZB, Unlu M, Kıran B, Bireller ES, Baran Y, Cakmakoglu B*. Molecular Mechanisms of Quercitrin-Induced Apoptosis in Non Small Cell Lung Cancer Cells. Archives of Medical Research, 2014; 45(6): 445-454.

Kiraz Y, Unlu M, Kartal Yandim M, Baran Y. Molecular Biology of Stem Cells. Hematolog, 2014: 4(2); 255-265.

Unlu M, Kiraz Y, Kacı FN, Baran Y. Multidrug Resistance in Chronic Myeloid Leukemia. Turkish Journal of Biology, 2014;38(6):806-816.

M. Topuzoğulları, E.V. Bulmuş Zareie, E. Dalgakıran, S. Dinçer, “pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization”, Polymer, 55(2): 525-534.

A. Wutka, V. Palagani, S. Barat, X. Chen, M. El Khatib, J. Götze, H. Belahmer, S. Zender, P. Bozko, N. P. Malek, R. R. Plentz, Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis, PLoS ONE, 2014, 9, 1-9 (DOI:10.1371/journal.pone.0095605)

V. Palagani, P. Bozko, M. El Khatib, H. Belahmer, N. Giese, B. Sipos, N. P. Malek, R. R. Plentz, Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression, Carcinogenesis, 2014, 35, 859-66 (DOI: 10.1093/carcin/bgt394)

2013

A. Adan, E. Apohan, Y. Baran. Resveratrol and quercetin induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology, 2013, 18(3),144-50.

A. Adan, M. Kartal-Yandim, G.Iskender, Y. Baran. Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer, Current Medicinal Chemistry, 2013, 20, 108-122.

BT. Kaymaz, N. Selvi, A. Adan, Ç. Aktan, C. Gündüz, G. Saydam, F. Şahin , VB. Çetintaş, Y. Baran, B. Kosova. Suppression of STAT5A and STAT5B Chronic Myeloid Leukemia Cells via siRNA and Antisense-Oligonucleotide Applications with the Induction of Apoptosis, American Journal of Blood Research, 2013; 3(1), 58-70.

A. Adan, A. Arslanoglu. Purification and biochemical characterization of an extracellular lipase from a psychrotolerant Pseudomonas fluorescens KE38, Turkish Journal of Biology, 2013, 37,538-546.

HD. Kiper, B. Tezcanli, A. Adan, N. Selvi, CB. Avci, BK. Kosova, G. Iskender, MK. Yandım, C. Gunduz, F. Sahin, Y. Baran, G. Saydam . STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells, Biomedicine and Pharmacotherapy, 2013; 67(6), 527-532.

Gokbulut AA, Yandım MK, Iskender G, Baran Y. Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer. Current Medicinal Chemistry, 2013; 20: 108-122.

Yandım MK, Apohan E, Baran Y. Therapeutic Potential of Targeting Ceramide/Glucosylceramide Pathway in Cancer. Cancer Chemotherapy and Pharmacology, 2013; 71(1): 13-20.

Kozanoglu I, Yandim MK, Cincin ZB, Ozdogu H, Cakmakoglu B, Baran Y. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma. Journal of Cancer Research and Clinical Oncology. 2013; 139(2): 327-335.

Kaymaz BT, Selvi N, Adan Gokbulut A, Aktan Ç, Gündüz C, Saydam G, Şahin F, Çetintaş VB, Baran Y, Kosova B*. Suppression of STAT5A and STAT5B Chronic Myeloid Leukemia Cells via siRNA and Antisense-Oligonucleotide Applications with the Induction of Apoptosis. American Journal of Blood Research, 2013; 3(1): 58-70.

Baran Y, Ceylan C, Camgoz A. The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy. Biomedicine and Pharmacotherapy, 2013; 67: 221-227.

Senarisoy M, Canturk P, Zencir S, Baran Y, Topcu Z*. Gossypol interferes with both type I and type II topoisomerases activities without generating strand breaks. Cell Biochemistry and Biophysics, 2013; 66(1): 199-204.

Turan T, Sanlı-Mohamed G*, Baran Y. Changes in Protein Profiles of Multiple Myeloma Cells in Response to Bortezomib. Leukemia and Lymphoma, 2013; 54(5): 1061-1068.

Camgoz A, Gencer EB, Ural AU, Baran Y. Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance. Leukemia and Lymphoma, 2013; 54(6): 1279-1287.

Sunay O, Can G, Cakir Z, Denek Z, Kozanoğlu I, Erdil G, Mustafa M, Baran Y. Autologous Rabbit Adipose Tissue Derived Mesenchymal Stem Cells For The Treatment Of Bone Injuries With Distraction Osteogenesis. Cytotherapy, 2013; 15(6): 690-702.

Firatligil B, Avci CB, Baran Y. mir-17 in Imatinib Resistance and Response to Tryosine Kinase Inhibitors in Chronic Myeloid Leukemia Cells. J. BUON, 2013; 18(2):437-441.

Gokbulut AA, Apohan E, Baran Y. Resveratrol and quercetin induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology, 2013; 18(3):144-50.

Bozkurt S*, Özkan T, Özmen F, Baran Y, Sunguroğlu A, Kansu E. The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells. Hematology, 2013, 18(4): 217-223.

Kiper HD, Tezcanli B, Gokbulut AA, Selvi N, Avci CB, Kosova BK, Iskender G, Yandım MK, Gunduz C, Sahin F, Baran Y, Saydam G. STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells. Biomedicine and Pharmacotherapy, 2013; 67(6):527-532.

Can G, Akpinar B, Baran Y, Zhivotovsky B, Olsson M*. 5-Fluouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells. Oncogene, 2013; 32(38):4529-4538.

Comert M, Baran Y, Saydam G. Changes in moleculer biology of Chronic Myeloid Leukemia in Tyrosine Kinase Inhibitor era. American Journal of Blood Research, 2013; (3):191-200.

Yilmaz AF, Saydam G, Sahin F, Baran Y. Granulocytic Sarcoma: A Systematic Review. American Journal of Blood Research 2013;3(4):265-270.

G. Uzunalan, M. Tuzlakoglu Ozturk, S. Dinçer, and K. Tuzlakoglu, “A Newly Designed Collagen-Based Bilayered Scaffold for Skin Tissue Regeneration”, J of Composites and Biodegradable Polymers (inaugrual issue), invited research article, Dec 2013, 1, 8-15.

Z. Ozdemir, M. Topuzogullari, I.A. Isoglu, S. Dincer, “RAFT-mediated synthesis of poly(N-(2-hydroxypropyl)methacrylamide-b-4-vinylpyridine) by conventional and microwave heating”, Polymer Bulletin, 2013, 2857-2872.

M. Topuzogullari, R.C. Koc, S. Dincer Isoglu, M. Bagirova, Z. Akdeste, S. Elcicek, O.N. Oztel, S. Yesilkir Baydar, S. Canim Ates, A.M. Allahverdiyev, “Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis”, J of Biomedical Science, 2013, DOI:10.1186/1423-0127-20-35.

Cevik S, Sanders AA, Van Wijk E, Boldt K, Clarke L, van Reeuwijk J, Hori Y, Horn N, Hetterschijt L, Wdowicz A, Mullins A, Kida K, Kaplan OI, van Beersum SE, Man Wu K, Letteboer SJ, Mans DA, Katada T, Kontani K, Ueffing M, Roepman R, Kremer H, Blacque OE. Active transport and diffusion barriers restrict Joubert Syndrome associated ARL13B/ARL-13 to an Inv-like ciliary membrane subdomain. PLoS Genet. 9(12):e1003977. doi: 10.1371/journal.pgen.1003977.

S. Emmrich, J. E. Katsman-Kuipers, K. Henk, M. E. Khatib, R. Jammal, F. Engeland, F. Dasci, C. M. Zwaan, M. L. den Boer, L. Verboon, J. Stary, A. Baruchel, V. de Haas, A. A. Danen-van Oorschot, M. Fornerod, R. Pieters, D. Reinhardt, J. H. Klusmann, M. M. van den Heuvel-Eibrink, miR-9 is a tumor suppressor in pediatric AML with t(8;21), Leukemia, 2013,  28, 1022-32 (DOI:10.1038/leu.2013.357)

M. El Khatib, P. Bozko, V. Palagani, N. P. Malek, L. Wilkens, R. R. Plentz, Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo, PLoS One, 2013, 8, 1-9 (DOI: 10.1371/journal.pone.0077433

M. E. Stankov, M. El Khatib, B. Kumar Thakur, K. Heitmann, D. Panayotova-Dimitrova, J. Schoening, J. P. Bourquin, N. Schweitzer, M. Leverkus, K. Welte, D: Reinhardt, Z. Li, S. H. Orkin, G. M. Behrens, J. H. Klusmann, Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy, Leukemia, 2013, 28, 577-88 (DOI:10.1038/leu.2013.264)

S. Zender, I. Nickeleit, T. Wuestefeld, I. Sörensen, D. Dauch, P. Bozko, M. El-Khatib, R. Geffers, H. Bektas, M. P. Manns, A. Gossler, L. Wilkens, R. Plentz, L. Zender, N. P. Malek. A critical role for notch signaling in the formation of cholangiocellular carcinomas, Cancer Cell, 2013, 23, 784-95 (DOI: 10.1016/j.ccr.2013.04.019)

M. El Khatib, A. Kalnytska, V. Palagani, U. Kossatz, M. P. Manns, N. P. Malek, L Wilkens, R. R. Plentz, Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma, Hepatology, 2013, 57, 1035-45 (DOI: 10.1002/hep.26147)

2012

O. Purclutepe , G. Iskender, HF. Kiper, B. Tezcanli, N. Selvi, CB. Avci, B. Kosova, A. Adan,  F. Sahin, Y. Baran, G. Saydam. Enalapril-Induced Apoptosis of Acute Promyeloctic Leukemia Cells  Involves STAT5A. Anticancer Research, 2012, 32, 2885-2894.

Ekiz HA, Can G, Baran Y. Role of autophagy in the progression and suppression of leukemias. Critical Reviews in Hematology/Oncology, 2012; 81(3): 275-285.

Bassoy EY and Baran Y. Bioactive Sphingolipids in Docetaxel-Induced Apoptosis in Human Prostate Cancer Cells. Biomedicine And Pharmacotherapy, 2012; 66(2): 103-110.

Purclutepe O, Iskender G, Kiper HD, Tezcanli B, Selvi N, Avci CB, Kosova B, Sahin F, Baran Y, Saydam G. Enalapril-Induced Apoptosis of Acute Promyeloctic Leukemia Cells  Involves STAT5A. Anticancer Research, 2012; 32: 2885-2894.

Ceylan C, Camgoz A, Baran Y. Macromolecular changes in nilotinib resistant K562 cells; an in vitro study by Fourier transform infrared spectroscopy. Technology in Cancer Research & Treatment, 2012; 11(4): 333-344.

Can G, Cakir Z, Kartal M, Gunduz U, Baran Y. Apoptotic Effects of Resveratrol, a Grape Polyphenol, on Imatinib Sensitive and Resistant K562 Cronic Myeloid Leukemia Cells. Anticancer Research, 2012; 32(7): 2673-8.

Baran Y, Saydam G. Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia. Journal of Blood Medicine, 2012; 3: 139–150.

Bozcuk H, Abali H, Coskun S, Aydıner A, Çinkaya A, Demirkazık A, Özet A, Yolcu A, Balkan A, Çavdar A, Kefeli AÜ, Uluç BO, Atasoy B, Demirkan B, Yalçın B, Eroğlu C, Yalman D, Kılıç D, Tunalı D, Fırat D, Seber E, Üçgül Çavuşoğlu E, Ulukaya E, Kaytan Sağlam E, Tezcanlı E, Eryılmaz E, Dinçbaş FÖ, Telli F, Yumuk F, Başaran G, Çağlar HB, Sönmez H, Yılmaz H, Engin H, Helvacı K, Sönmez K, Koral L, Artaç M, Fuat Eren M, Koçar M, Beyzadeoğlu M, Akın M, Benekli M, Cengiz M, Erman M, Yıldız M, Doğan M, Balkan M, Eraktuğ N, Ünal OÜ, Şencan O, Erpolat Ö, Saip P, Kılıçkap S, Selçuk Seber SO, Paydaş S, Sarıhan S, Kömürcü Ş, Demirkasımoğlu T, Korkmaz T, Yetişyiğit T, Yavuzşen T, Evrensel T, Akman T, Abacıoğlu U, Kefeli U, Egeli Ü, Elgin Y, Baran Y, Bulut Z (Alphabetical order). The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis. World Journal of Surgical Oncology.  2012; 10(1): 161-

Kaplan OI, Doroquez DB, Cevik S, Bowie RV, Clarke L, Sanders AA, Kida K, Rappoport JZ, Sengupta P, Blacque OE. Endocytosis genes facilitate protein and membrane transport in C.elegans sensory cilia. Curr Biol.22(6):451-60. doi: 10.1016/j.cub.2012.01.060.

S. Cetinel, S.Dinçer, A. Cebeci, E. Oren, JD. Whitteker, D. Schwartz, NG. Karaguler, C. Tamerler, M. Sarikaya, “Peptides to bridge biological-platinum materials interface”, Bioinspired, Biomimetic and Nanobiomaterials, 2012, 1, 143-53, DOI:10.1680.

V. Palagani, M. El Khatib, U. Kossatz, P. Bozko, M. R. Müller, M. P. Manns, T. Krech, N. P. Malek, R. R. Plentz, Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX, PLoS One, 2012, 7, 1-11 (doi: 10.1371/journal.pone.0046514)

V. Palagani, M. El Khatib, T. Krech, M. P. Manns, N. P. Malek, R. R. Plentz, Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer, Anticancer Res, 2012, 32, 1747-55

Y.Z. Ohkubo, T.V. Pogorelov, M.J. Arcario, G.A. Christensen, E. Tajkhorshid, Accelerating membrane insertion of peripheral proteins with a novel membrane mimetic model, Biophysical Journal 2012, 9, 2130 (DOI: 10.1016/j.bpj.2012.03.015

2011

A. Adan, M. Kartal, Y. Baran. Molecular Biology of Breast Cancer. Book Chapter, Molecular Approaches to Breast Cancer, 2011, ISBN: 978-975-483-928-9.

Baran Y. Hücre Ölümü Çalışmalarında Gen Aktarım Teknikleri. 2011, Kitap Bölümü, I. Hücre Ölümü Araştirma Teknikleri Teorik Kursu, ISBN: 978-975-441-349-6.

Gucluler G, Piskin O, Baran Y. The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells. J BUON, 2011; 16(4): 646-651.

Cakir Z, Saydam G, Sahin F, Baran Y. The Roles Of Bioactive Sphingolipids In Resveratrol-Induced Apoptosis In HL60 Acute Myeloid Leukemia Cells. Journal Of Cancer Research And Clinical Oncology, 2011; 137: 279–286.

Avcı CB, Gunduz C, Baran Y, Sahin F, Yilmaz S, Dogan ZO, Saydam G*. Caffeic Acid Phenethyl Esther Triggers Apoptosis Through Induction of Loss of Mitochondrial Membrane Potential in CCRF-CEM. Journal of Cancer Research and Clinical Oncology, 2011; 137: 41-47.  

Can G, Ekiz A, Baran Y. Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells. Hematology, 2011; 16(2): 95-99.

Kartal M, Saydam G, Sahin, Baran Y. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. Nutrition and Cancer; An International Journal, 2011; 63(4): 637-644.

Sanli MG, Turan T, Ekiz HA, Baran Y. The importance of protein profiling in the diagnosis and treatment of hematologic malignancies. Turkish Journal of Hematology, 2011; 28: 1-14.

Mutlu P, Baran Y, Ural AU, Avcu F, Dirican B, Beyzadeoglu M, Gündüz U*. Effect Of Cobalt-60 (Γ Radiation) On Multidrug Resistant Multiple Myeloma Cell Lines. Cell Biology International, 2011; 35(7): 721-5.

Salas A, Ponnusamy S, Senkal CE, Meyers MA, Selvam SP, Saddoughi SA, Apohan E, Sentelle RD, Smith C, Gault CR, Obeid LM, El-Shewy HM, Oaks J, Ramasamy S, Marcucci G, Baran Y, Mahajan S, Fernandes D, Stuart RK, Perrotti D, Ogretmen B*. : Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood, 2011; 117(22): 5941-5952.

Ekiz HA, Baran Y. Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias. Anti-Cancer Agents in Medicinal Chemistry, 2011; 11: 385-397.

Camgoz A, Gencer EB, Ural AU, Avcu F, Baran Y. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells. Leukemia and Lymphoma, 2011; 52(8): 1574-84.

Firinci F*, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O. Mesenchymal Stem Cells Ameliorate The Histopathological Changes in a Murine Model of Chronic Asthma. International Immunopharmacology, 2011; 11(8): 1120-1126.

Avcı ÇB, Yılmaz S, Dogan ZO, Saydam G, Dodurga Y, Ekiz HA, Kartal M, Sahin F, Baran Y, Gunduz C. Quercetin-induced Apoptosis involves increased HTERT enzyme activity of Leukemic Cells. Hematology, 2011; 16(5): 303-307.

Baran Y, Bielawski J, Gunduz U, Ogretmen B. Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.  Journal of Cancer Research and Clinical Oncology, 2011; 137(10): 1535-1544.

Gencer EB, Ural AU, Avcu F, Baran Y. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes. Annals of Hematology, 2011; 90(11): 1265-1275.

Avcu F, Avcu N*, Er N, Kansu Ö, Baran Y, Pekel A, Ural AU. The Cytotoxic and Apoptotic-Necrotic Effects of Whitening Materials on Human Gingival Fibroblasts.  Clinical Dentistry and Research, 2011; 35(1): 3-11.

Baran Y, Zencir S, Çakır Z, Öztürk E, Topçu Z*.  Imatinib-induced apoptosis; A possible link to topoisomerase enzyme inhibition. Journal of Clinical Pharmacy and Therapeutics, 2011; 36(6): 673-679.

Adan A, Kartal M, Baran Y. Meme Kanserinin Moleküler Biyolojisi (Molecular Biology of Breast Cancer). 2011, Kitap Bölümü, Meme Kanserine Moleküler Yaklaşım Molecular Approaches to Breast Cancer, ISBN: 978-975-483-928-9.

Baran Y. Hücrenin Kritik Kararı; Yaşamak ya da Ölmek. 2011, Kitap Bölümü, I. Hücre Ölümü Araştirma Teknikleri Teorik Kursu, ISBN: 978-975-441-349-6.

2010

Ekiz HA, Baran Y. Therapeutic Applications of Bioactive Sphingolipids in Hematological Malignancies. International Journal of Cancer, 2010; 127(7): 1497-506.

Kosova B, Tezcanli B, Ekiz HA, Cakir Z, Selvi N, Dalmizrak A, Kartal M, Gunduz U, Baran Y. Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells. Leukemia and Lymphoma, 2010; 51(10): 1895-901.

Ekiz A, Can G, Gunduz U, Baran Y. Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts. Hematology, 2010; 15(1): 33-38.

Goktas S, Baran Y, Ural AU, Yazici S*, Aydur E, Basal S,  Avcu F, Pekel A, Dirican B, Beyzadeoglu M. Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells. Urology, 2010; 75(4): 793-798.

Baran Y, Oztekin C, Bassoy EY. Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. Cancer Investigation, 2010; 28(6): 623-628.

Cevik S, Hori Y, Kaplan OI, Kida K, Toivenon T, Foley-Fisher C, Cottell D, Katada T, Kontani K, Blacque OE. Joubert syndrome Arl13b functions at ciliary membranes and stabilizes protein transport in Caenorhabditis elegans. J Cell Biol. 188(6):953-69. doi: 10.1083/jcb.200908133.

Kaplan OI, Molla-Herman A, Cevik S, Ghossoub R, Kida K, Kimura Y, Jenkins P, Martens JR, Setou M, Benmerah A, Blacque OE. The AP-1 clathrin adaptor facilitates cilium formation and functions with RAB-8 in C.elegans ciliary membrane transport. J Cell Sci.  123(Pt 22):3966-77. doi: 10.1242/jcs.073908.

S.Dinçer, M.Türk, A.Karagöz, G.Uzunalan, "Potential c-myc Antisense Oligonucleotide Carriers: PCl/PEG/PEI and PLL/PEG/PEI", Artificial Cells, Blood Substitutes, and Biotechnology, 1-12 pp., 2010, DOI: 10.3109/10731199.2010.506852.

A.Karagöz, S.Dinçer, "Microwave-Assisted Synthesis of Poly(e- caprolactone)-block-poly(ethylene glycol) and Poly(lactide)-block-poly(ethylene glycol)", Macromolecular Symposia, 131-137 pp., 2010, DOI: 10.1002/masy.200900170.

M. El-Khatib, F. Geara, M. J. Haddadin, H. Gali-Muhtasib, Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21, Radiat Oncol, 2010, 5, 1747-55 (DOI: 10.1186/1748-717X-5-107)

2009

Abaan DO, Mutlu PK, Baran Y, Atalay MC, Gunduz U*. Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients. Cancer Investigation, 2009; 27(2): 201-205.

Karabulut B, Erten C, Gul MK, Cengiz E, Karaca B, Kucukzeybek Y, Gorumlu G, Atmaca H, Uzunoglu S, Sanli Ua, Baran Y, Uslu R*. Docetaxel/Zoledronic Acid Combination Triggers Apoptosis Synergistically Through Downregulating Antiapoptotic Bcl-2 Protein Level In Hormone-Refractory Prostate Cancer Cells. Cell Biology International, 2009; 33(2): 239-246.

Gucluler G, Baran Y. Docetaxel Enhances the Cytotoxic Effects of Imatinib on Philadelphia Positive Human Chronic Myeloid Leukemia Cells. Hematology, 2009; 14(3): 139-144.

Baran Y, Oztekin C, Bassoy EY. Inhibition of Proteasome by Bortezomib Increased Chemosensitivity of BCR/ABL Positive Human K562 Chronic Myleoid Leukemia Cells to Imatinib. Health, 2009; 1(4): 320-324.

Simonis N, Rual JF, Carvunis AR, Tasan M, Lemmens I, Hirozane-Kishikawa T, Hao T, Sahalie JM, Venkatesan K, Gebreab F, Cevik S, Klitgord N, Fan C, Braun P, Li N, Ayivi-Guedehoussou N, Dann E, Bertin N, Szeto D, Dricot A, Yildirim MA, Lin C, de Smet AS, Kao HL, Simon C, Smolyar A, Ahn JS, Tewari M, Boxem M, Milstein S, Yu H, Dreze M, Vandenhaute J, Gunsalus KC, Cusick ME, Hill DE, Tavernier J, Roth FP, Vidal M. Emprically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods. 6(1):47-54.

Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, Vinayagam A, Yu H, Szeto D, Borick H, Dricot A, Klitgord N, Murray RR, Lin C, Lalowski M, Timm J, Rau K, Boone C, Braun P, Cusick ME, Roth FP, Hill DE, Tavernier J, Wanker EE, Barabási AL, Vidal M. An empirical framework for binary interactome mapping. Nat Methods. 6(1):83-90. doi: 10.1038/nmeth.1280.

S. Dinçer , E. K. Oskay , A. K. Piskin , N. D. Zeybek , E. Pişkin, Growth inhibition of SK-MEL-30 human melanoma cells by antisense c-myc oligonucleotides delivered by poly(N-isopropylacrylamide)/poly(ethyleneimine) copolymer, Journal of Tissue Engineering and Regenerative Medicine, DOI: 10.1002/term.239.

2008

Baran Y, Ural AU, Avcu F, Sarper M, Elçi P, Pekel A. Optimization of Transfection of Green Fluorescent Protein in Pursuing Mesenchymal Stem Cells, In Vivo. Turkish Journal of Hematology, 2008; 25(4): 172-175.

Ural AU*, Avcu F, Baran Y. Bisphosphonate treatment and radiotherapy in metastatic breast cancer. Medical Oncology, 2008; 25(3): 350-355.

Blacque OE, Cevik S, Kaplan OI. Intraflagellar transport: from molecular characterisation to mechanism. Front Biosci. 2008 Jan 1;13:2633-52. Review.

S. Dincer, C. Tamerler, M. Sarıkaya, E. Piskin, "'Photoresponsive peptide–azobenzene conjugates that specifically interact with platinum surfaces", Surface Science, 1757–1762 pp., 2008, DOI: 10.1016/j.susc.2008.03.011.

2007

Gorduysus M*, Avcu N, Gorduysus O, Pekel A, Baran Y, Avcu F, Ural AU. Cytotoxic Effects of Four Different Endodontic Materials in Human Periodontal Ligament Fibroblasts. Journal of Endodontics, 2007; 33(12): 1450-1454.

Ural AU*, Avcu F, Baran Y. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 2007; 110(2): 469-470.

Baran Y, Gunduz U. Kronik Miyelositer Lösemi Genetiği (Genetics of chronic myeloid leukemia). Journal of Turkish Internal Medicine, 2007; 3(2): 50-55

 Baran Y, Gur B, Kaya P, Ural AU, Avcu F, Gunduz U. Upregulation of multidrug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hematology, 2007; 12(6): 511-517.

Baran Y, Ural AU, Gunduz U. Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells. Hematology, 2007; 12(6): 497-503.

Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B*. Alterations of Ceramide/Sphingosine 1-Phosphate Rheostat Involved in the Regulation of Resistance to Imatinib-induced Apoptosis in K562 Human Chronic Myeloid Leukemia Cells. Journal of Biological Chemistry, 2007; 282(15): 10922-10934.

U.O.S. Seker, B. Wilson, S. Dincer, I.W. Kim, E.E. Oren, J.S. Evans, C. Tamerler, M. Sarikaya, "Adsorption Behavior of Linear and Cyclic Genetically Engineered Platinum Binding Peptides", Langmuir, 7895-7900 pp., 2007, DOI: 10.1021/la700446g.

M. Turk, S. Dincer and E. Piskin, "Smart and cationic poly(NIPA)/PEI block copolymers as non-viral vectors: in vitro and in vivo transfection studies", Journal of Tissue Engineering and Regenerative Medicine, 377-378 pp., 2007, DOI: 10.1002/term.47.

Z.M.O. Rzaev, S. Dincer, E. Piskin, "Functional copolymers of N-isopropylacrylamide for bioengineering applications", Progress in Polymer Science, 534-595 pp., 2007, DOI: 10.1016/j.progpolymsci.2007.01.006.

2006

Baran Y, Gunduz U, Ural AU. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine. Experimental Oncology, 2006; 28(2): 163-165.

S. Dinçer, Z.M.O. Rzaev, E Pişkin, “Synthesis and Characterization of Stimuli-Responsive Poly(N-isopropylacrylamide-co-N-vinyl-2-pyrrolidone)”, Journal of Polymer Research, 121-131 pp., 13, 2006, DOI: 10.1007/s10965-005-9014-x.

2005

Baran Y, Gündüz U, Ural AU. Expression of multidrug resistance (MDR1) gene in human promyelocytic leukemia cell line selected with vincristine. Turkish Journal of Cancer, 2005; 35(2): 88-92.

Önalan G*, Selam B, Baran Y, Cincik M, Onalan R, Gündüz U, Ural AU, Pabuççu R. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF. Human Reproduction, 2005; 20(9): 2391-2395.

Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M. Towards a proteome-scale map of the human protein-protein interaction network. Nature. 20;437(7062):1173-8.

S. Dinçer, M. Türk, E. Pişkin, "Intelligent Polymers as nonviral vectors", Gene Therapy, S139-S145 pp., 2005 , DOI: 10.1038/sj.gt.3302628.

2004

M. Türk, S. Dinçer, I.G. Yuluğ , E. Pişkin, "In vitro Transfection of HeLa Cells with Temperature Sensitive Polycationic Copolymers", Journal of Controlled Release, 325-340 pp., 2004 , DOI: 10.1016/j.jconrel.2004.01.013.


E. Pişkin, S .Dinçer, M. Turk, "Gene delivery-intelligent but just at the beginning", Journal of Biomaterials Science Polymer Edition, 1181-1202 pp., 2004 , DOI: 10.1163/1568562041753016.

2003

C. Tamerler, S. Dincer, D. Heidel, M.H. Zareie, M. Sarikaya, ‘Biomimetic multifunctional molecular coatings using engineered proteins’, Progress in Organic Coatings, 47, 2003, 267-274, DOI: 10.1016/j.porgcoat.2003.08.014.

C. Tamerler, S. Dinçer, D. Heidel, N. Karagűler, and M. Sarikaya, "Combinatorial Peptide Libraries for Selecting Inorganic-Binding Proteins: A Step in Molecular Biomimetics", Materials Research Society (MRS) Proceedings, N8.1.1-N8.1.10 pp., 2003.

G. David, V. Alupei, B.C. Simionescu, S. Dincer, E. Piskin, "Poly(N-isopropylacrylamide)/poly[(N-acetylimino)ethylene] thermosensitive block and graft copolymers", European Polymer Journal, 1209–1213 pp., 2003 , DOI: 10.1016/S0014-3057(02)00369-5.

H. Kesim, Z.M.O. Rzaev, S. Dincer, E. Piskin, "Functional bioengineering copolymers. II. Synthesis and characterization of amphiphilic poly(N-isopropyl acrylamide-co-maleic anhydride) and its macrobranched derivatives", Polymer, 2897–2909 pp., 2003 , DOI: 10.1016/S0032-3861(03)00177-0.

2002

S. Dincer, V. Koseli, H. Kesim, Z.M.O. Rzaev, E. Piskin, "Radical copolymerization of N-isopropylacrylamide with anhydrides of maleic and citraconic acids", European Polymer Journal, 2143–2152 pp., 2002 , DOI: 10.1016/S0014-3057(02)00127-1.

H. Zareie, S. Dinçer, E. Piskin, "Observation of Phase Transition of Thermo-responsive Poly(NIPA)-PEI Block Copolymers by STM", Journal of Colloid and Interface Science, 424-428 pp., 2002 , DOI: 10.1006/jcis.2002.8439.

S. Dinçer, S.A. Tuncel, E. Piskin, "A Potential Gene Delivery Vector: N-Isopropylacrylamide-ethyleneimine block copolymers", Macromolecular Chemistry and Physics, 1460-1465 pp., 2002, DOI: 10.1002/1521-3935(200207)203:10/11<1460::AID-MACP1460>3.0.CO;2-O.